|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Laoukili J, Kooistra MR, Brás A, Kauw J,
Kerkhoven RM, Morrison A, Clevers H and Medema RH: FoxM1 is
required for execution of the mitotic programme and chromosome
stability. Nat Cell Biol. 7:126–136. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sullivan C, Liu Y, Shen J, Curtis A,
Newman C, Hock JM and Li X: Novel interactions between FOXM1 and
CDC25A regulate the cell cycle. PLoS One. 7:e512772012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakamura S, Hirano I, Okinaka K, Takemura
T, Yokota D, Ono T, Shigeno K, Shibata K, Fujisawa S and Ohnishi K:
The FOXM1 transcriptional factor promotes the proliferation of
leukemia cells through modulation of cell cycle progression in
acute myeloid leukemia. Carcinogenesis. 31:2012–2021. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu LL, Zhang DH, Mao X, Zhang XH and
Zhang B: Over-expression of FoxM1 is associated with adverse
prognosis and FLT3-ITD in acute myeloid leukemia. Biochem Biophys
Res Commun. 446:280–285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu XR, Chen YH, Liu DM, Sha JJ, Xuan HQ,
Bo JJ and Huang YR: Increased expression of forkhead box M1 protein
is associated with poor prognosis in clear cell renal cell
carcinoma. Med Oncol. 30:3462013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takata A, Takiguchi S, Okada K, Takahashi
T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Mori M and Doki Y:
Clinicopathological and prognostic significance of FOXM1 expression
in esophageal squamous cell carcinoma. Anticancer Res.
34:2427–2432. 2014.PubMed/NCBI
|
|
9
|
Wang Y, Wen L, Zhao SH, Ai ZH, Guo JZ and
Liu WC: FoxM1 expression is significantly associated with
cisplatin-based chemotherapy resistance and poor prognosis in
advanced non-small cell lung cancer patients. Lung Cancer.
79:173–179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang C, Xie D, Cui J, Li Q, Gao Y and Xie
K: FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal
transition and metastasis via upregulation of expression of the
urokinase plasminogen activator system. Clin Cancer Res.
20:1477–1488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai Y, Balli D, Ustiyan V, Fulford L,
Hiller A, Misetic V, Zhang Y, Paluch AM, Waltz SE, Kasper S and
Kalin TV: Foxm1 expression in prostate epithelial cells is
essential for prostate carcinogenesis. J Biol Chem.
288:22527–22541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wen N, Wang Y, Wen L, Zhao SH, Ai ZH, Wang
Y, Wu B, Lu HX, Yang H, Liu WC and Li Y: Overexpression of FOXM1
predicts poor prognosis and promotes cancer cell proliferation,
migration and invasion in epithelial ovarian cancer. J Transl Med.
12:1342014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kong FF, Qu ZQ, Yuan HH, Wang JY, Zhao M,
Guo YH, Shi J, Gong XD, Zhu YL, Liu F, et al: Overexpression of
FOXM1 is associated with EMT and is a predictor of poor prognosis
in non-small cell lung cancer. Oncol Rep. 31:2660–2668. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weber CE, Li NY, Wai PY and Kuo PC:
Epithelial-mesenchymal transition, TGF-β, and osteopontin in wound
healing and tissue remodeling after injury. J Burn Care Res.
33:311–318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin SY, Peng AP, Huang LT, Wang YT, Lan CW
and Yang NS: The phytochemical shikonin stimulates
epithelial-mesenchymal transition (EMT) in skin wound healing. Evid
Based Complement Alternat Med. 2013:2627962013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grant CM and Kyprianou N: Epithelial
mesenchymal transition (EMT) in prostate growth and tumor
progression. Transl Androl Urol. 2:202–211. 2013.PubMed/NCBI
|
|
18
|
Ombrato L and Malanchi I: The EMT
universe: Space between cancer cell dissemination and metastasis
initiation. Crit Rev Oncog. 19:349–361. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kwasnicki A, Jeevan D, Braun A, Murali R
and Jhanwar-Uniyal M: Involvement of mTOR signaling pathways in
regulating growth and dissemination of metastatic brain tumors via
EMT. Anticancer Res. 35:689–696. 2015.PubMed/NCBI
|
|
20
|
Yoshida T, Ozawa Y, Kimura T, Sato Y,
Kuznetsov G, Xu S, Uesugi M, Agoulnik S, Taylor N, Funahashi Y and
Matsui J: Eribulin mesilate suppresses experimental metastasis of
breast cancer cells by reversing phenotype from
epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial
transition (MET) states. Br J Cancer. 110:1497–1505. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ueno H, Shinto E, Kajiwara Y, Fukazawa S,
Shimazaki H, Yamamoto J and Hase K: Prognostic impact of
histological categorisation of epithelial-mesenchymal transition in
colorectal cancer. Br J Cancer. 111:2082–2090. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miao L, Xiong X, Lin Y, Cheng Y, Lu J,
Zhang J and Cheng N: Down-regulation of FoxM1 leads to the
inhibition of the epithelial-mesenchymal transition in gastric
cancer cells. Cancer Genet. 207:75–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO Classification of Tumours of the Digestive System.
4th. IARC Press; Lyon: 2010
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu J and Verkman AS: Increased migration
and metastatic potential of tumor cells expressing aquaporin water
channels. FASEB J. 20:1892–1894. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu D, Zhang Z and Kong CZ: High FOXM1
expression was associated with bladder carcinogenesis. Tumour Biol.
34:1131–1138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia JT, Wang H, Liang LJ, Peng BG, Wu ZF,
Chen LZ, Xue L, Li Z and Li W: Overexpression of FOXM1 is
associated with poor prognosis and clinicopathologic stage of
pancreatic ductal adenocarcinoma. Pancreas. 41:629–635. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang K, Jiang L, Hu Y, Yu J, Chen H, Yao Y
and Zhu X: Short hairpin RNA-mediated gene knockdown of FOXM1
inhibits the proliferation and metastasis of human colon cancer
cells through reversal of epithelial-to-mesenchymal transformation.
J Exp Clin Cancer Res. 34:402015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Theys J, Jutten B, Habets R, Paesmans K,
Groot AJ, Lambin P, Wouters BG, Lammering G and Vooijs M:
E-Cadherin loss associated with EMT promotes radioresistance in
human tumor cells. Radiother Oncol. 99:392–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen L, Muñoz-Antonia T and Cress WD:
Trim28 contributes to EMT via regulation of E-cadherin and
N-cadherin in lung cancer cell lines. PLoS One. 9:e1010402014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mohamet L, Hawkins K and Ward CM: Loss of
function of e-cadherin in embryonic stem cells and the relevance to
models of tumorigenesis. J Oncol. 2011:3526162011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He X, Chen Z, Jia M and Zhao X:
Downregulated E-cadherin expression indicates worse prognosis in
Asian patients with colorectal cancer: Evidence from meta-analysis.
PLoS One. 8:e708582013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yun JA, Kim SH, Hong HK, Yun SH, Kim HC,
Chun HK, Cho YB and Lee WY: Loss of E-Cadherin expression is
associated with a poor prognosis in stage III colorectal cancer.
Oncology. 86:318–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang C, Qiu Z, Wang L, Peng Z, Jia Z,
Logsdon CD, Le X, Wei D, Huang S and Xie K: A novel FoxM1-caveolin
signaling pathway promotes pancreatic cancer invasion and
metastasis. Cancer Res. 72:655–665. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai
MH, Liu HC, Zhang RY and Liu C: FoxM1 overexpression promotes
epithelial-mesenchymal transition and metastasis of hepatocellular
carcinoma. World J Gastroenterol. 21:196–213. 2015. View Article : Google Scholar : PubMed/NCBI
|
